Vencanna Ventures Inc. (the "Company" or "Vencanna") announced, effective immediately, the change of its corporate name from Top Strike Resources Corp. to Vencanna Ventures Inc. and the execution of a second amended and restated definitive unit exchange agreement (as amended, the "Amended Agreement") with The Cannavative Group LLC ("Cannavative") amending the agreement originally entered into on April 25, 2022, and subsequently amended and restated on August 16, 2023. Management and the board of directors will be comprised of professionals from both entities, forming an integrated team capable of executing the Company's forward-looking business plan.

This plan includes expanding market penetration in Nevada, venturing into New Jersey, and exploring potential investment opportunities. The following outlines the Company's core team and directors post-closing, which include the addition of a representative of Cannavative as a director of the Company and the appointment of a representative of Cannavative as an officer of the Company. Jason Crum, Chief Revenue Officer: Mr. Crum currently holds the positions of President and Chief Revenue Officer at Cannavative, bringing over two decades of diverse experience in Consumer Packaged Goods (CPG) and Fast-Moving Consumer Goods (FMCG), specifically in alcohol sales management.

His extensive background includes roles at industry giants like MillerCoors and Treasury Wine Estates, where he directly oversaw supply, distribution, and brand building in the beer and wine sectors. Jason's expertise encompasses team development, strategic analytics optimization, and operational efficiency enhancements. Since joining Cannavative in 2019, he has played a crucial role in significantly expanding the company's penetration in Nevada dispensaries and driving sales growth.

Mr. Crum is an alumnus of UT Austin. Dr. Scott Wrye MD, Independent Director: Dr. Wrye, a co-founder and director of Cannavative, brings a wealth of expertise as a private practicing physician and specialist in Cosmetic, Plastic & Reconstructive Surgery based in Reno, Nevada. Early on he championed the cause of medical cannabis, actively educating and assisting numerous patients in northern Nevada to legally access medical cannabis.

Beyond his community advocacy, Dr. Wrye has played a pivotal role in guiding Cannavative's product and brand development. Dr. Wrye is a graduate of New York State University, College of Medicine. Effective as of closing of the Transaction, Matthew Christopherson and Smoke Wallin will be stepping down from the Company's board.